Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1988 1
1989 1
2003 1
2009 2
2010 6
2011 6
2012 5
2014 4
2015 3
2016 9
2017 13
2018 10
2019 2
2020 3
2021 2
2022 9
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

74 results

Results by year

Filters applied: . Clear all
Page 1
Therapy for Stage IV Non-Small-Cell Lung Cancer With Driver Alterations: ASCO Living Guideline.
Singh N, Temin S, Baker S Jr, Blanchard E, Brahmer JR, Celano P, Duma N, Ellis PM, Elkins IB, Haddad RY, Hesketh PJ, Jain D, Johnson DH, Leighl NB, Mamdani H, Masters G, Moffitt PR, Phillips T, Riely GJ, Robinson AG, Rosell R, Schiller JH, Schneider BJ, Spigel DR, Jaiyesimi IA. Singh N, et al. Among authors: temin s. J Clin Oncol. 2022 Oct 1;40(28):3310-3322. doi: 10.1200/JCO.22.00824. Epub 2022 Jul 11. J Clin Oncol. 2022. PMID: 35816666 Updated.
Secondary Prevention of Cervical Cancer: ASCO Resource-Stratified Guideline Update.
Shastri SS, Temin S, Almonte M, Basu P, Campos NG, Gravitt PE, Gupta V, Lombe DC, Murillo R, Nakisige C, Ogilvie G, Pinder LF, Poli UR, Qiao Y, Woo YL, Jeronimo J. Shastri SS, et al. Among authors: temin s. JCO Glob Oncol. 2022 Sep;8:e2200217. doi: 10.1200/GO.22.00217. JCO Glob Oncol. 2022. PMID: 36162041 Free PMC article. Review.
Therapy for Stage IV Non-Small-Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline.
Singh N, Temin S, Baker S Jr, Blanchard E, Brahmer JR, Celano P, Duma N, Ellis PM, Elkins IB, Haddad RY, Hesketh PJ, Jain D, Johnson DH, Leighl NB, Mamdani H, Masters G, Moffitt PR, Phillips T, Riely GJ, Robinson AG, Rosell R, Schiller JH, Schneider BJ, Spigel DR, Jaiyesimi IA. Singh N, et al. Among authors: temin s. J Clin Oncol. 2022 Oct 1;40(28):3323-3343. doi: 10.1200/JCO.22.00825. Epub 2022 Jul 11. J Clin Oncol. 2022. PMID: 35816668 Updated.
Management of Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer and Brain Metastases: ASCO Guideline Update.
Ramakrishna N, Anders CK, Lin NU, Morikawa A, Temin S, Chandarlapaty S, Crews JR, Davidson NE, Franzoi MAB, Kirshner JJ, Krop IE, Patt DA, Perlmutter J, Giordano SH. Ramakrishna N, et al. Among authors: temin s. J Clin Oncol. 2022 Aug 10;40(23):2636-2655. doi: 10.1200/JCO.22.00520. Epub 2022 May 31. J Clin Oncol. 2022. PMID: 35640075
Reply to M.E.H.M. Van Hoef.
Hanna N, Temin S, Oliver TK, Masters G. Hanna N, et al. Among authors: temin s. J Clin Oncol. 2018 Feb 1;36(4):427-428. doi: 10.1200/JCO.2017.76.3599. Epub 2017 Nov 22. J Clin Oncol. 2018. PMID: 29166169 No abstract available.
ASCO Resource-Stratified Guidelines: Methods and Opportunities.
Al-Sukhun S, Temin S, Chavez-MacGregor M, Denduluri N, Oliver TK, Pyle D, Shah MA, Gralow J. Al-Sukhun S, et al. Among authors: temin s. J Glob Oncol. 2018 Jul;4:1-8. doi: 10.1200/JGO.18.00113. J Glob Oncol. 2018. PMID: 30110223 Free PMC article.
Systematic review on hormone receptor testing in breast cancer.
Nofech-Mozes S, Vella ET, Dhesy-Thind S, Hagerty KL, Mangu PB, Temin S, Hanna WM. Nofech-Mozes S, et al. Among authors: temin s. Appl Immunohistochem Mol Morphol. 2012 May;20(3):214-63. doi: 10.1097/PAI.0b013e318234aa12. Appl Immunohistochem Mol Morphol. 2012. PMID: 22505008 Review.
74 results